Sword Health, a NYC-based tech-enabled provider of musculoskeletal care, raised an additional $9m in Series A funding.
The round addition, which brought total funding raised to date to $17m, was led by Khosla Ventures, with participation from Founders Fund, Green Innovations, Lachy Groom, Vesalius Biocapital and Faber Ventures.
The additional capital will go towards increasing the company’s market presence, investing in distribution, partnerships, sales and marketing, and making strategic product, clinical and operational investments to improve member experience and outcomes.
Founded in 2015 by CEO Virgilio Bento, Sword is a tech-enabled provider of musculoskeletal care that has developed and tested therapeutic intervention that treats preventive, chronic and post-surgical pain in-market and clinically. Since launching in 2015, the company has worked with insurers, health systems and employers in Europe, Australia and the U.S.
This extension follows the first closing of Sword’s Series A led by Khosla Ventures in April 2019 and a seed round of $4.6m in April 2018, led by European VCs and angel investors. This latest raise brings the company’s total funding to $22m since the company was founded in 2015.
Sword has offices in New York City, Chicago, Salt Lake City, Sydney and Porto.